Answer
The Mirvaso 3 mg/g (brimonidine tartrate) gel product information states that pharmaceutical incompatibilities are “Not applicable.”
Sources for this answer
- Mirvaso 3mg/g GelGalderma (U.K.) Limited · emc · SmPC §6.2 Incompatibilities · Version 12Document updated
Sources checked